Citation Impact
Citing Papers
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα–Driven Leukemia
2015
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
2017
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast Cells
2009
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Functional classes of bronchial mucosa genes that are differentially expressed in asthma
2004
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
2006
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
CpG islands and the regulation of transcription
2011 Standout
Single-cell-resolution transcriptome map of human, chimpanzee, bonobo, and macaque brains
2020 StandoutNobel
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
2010 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Selective Targeting of Cancer Stem Cells
2007
IgE and mast cells in allergic disease
2012 Standout
The Epigenomics of Cancer
2007 Standout
DNA methylation: roles in mammalian development
2013 Standout
Classical and novel retinoids: their targets in cancer therapy
2002
Glutathione, photosynthesis and the redox regulation of stress-responsive gene expression
2005
Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations
2006
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Serum pulmonary and activation‐regulated chemokine/CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosis
2005
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
2005
The Mammalian Epigenome
2007 Standout
Histone deacetylase inhibitors: from target to clinical trials
2002
Association of MicroRNA-223 Expression with Hepatic Ischemia/Reperfusion Injury in Mice
2008
Molecular genetics of acute promyelocytic leukemia
1999
DNA methylation landscapes: provocative insights from epigenomics
2008 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Lsh is involved in de novo methylation of DNA
2006
Biology and management of relapsed acute myeloid leukaemia
2005
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients
2006
miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death
2012
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
2008
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Evidence for an instructive mechanism of de novo methylation in cancer cells
2006
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Eicosanoids and cancer
2010 Standout
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Epigenetic modifications and human disease
2010 Standout
Histone deacetylase inhibitors in clinical development
2004
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
In Vivo Analysis of Aicda Gene Regulation: A Critical Balance between Upstream Enhancers and Intronic Silencers Governs Appropriate Expression
2013 StandoutNobel
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
2017
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Artificial intelligence in radiology
2018 Standout
Id family of helix-loop-helix proteins in cancer
2005
Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells
2007
Evolution of primate gene expression
2006 StandoutNobel
Environmental epigenomics and disease susceptibility
2007 Standout
Retinoids Regulate the Repairing Process of the Podocytes in Puromycin Aminonucleoside-induced Nephrotic Rats
2003 StandoutNobel
Asthma
2005
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
1999
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
Histone Acetyltransferases
2001 Standout
Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia
2000
Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5
2003
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cells
2002
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia
2005
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes
2005
An Increased Expression of Cysteinyl Leukotriene 2 Receptor in Colorectal Adenocarcinomas Correlates with High Differentiation
2007
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
1999
Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders
2003
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
2004
Works of Wei Ding being referenced
A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features
2016
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
2005
Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions
1999
Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure
2006
Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5β
2009
Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations
2015
Microarray profile of differentially expressed genes in a monkey model of allergic asthma
2002
The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4–10 ng/mL
2008
Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors
2005
Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-transretinoic acid and histone deacetylase inhibitors in vitro and in vivo
2002
Leukemic Cellular Retinoic Acid Resistance and Missense Mutations in the PML-RAR Fusion Gene After Relapse of Acute Promyelocytic Leukemia From Treatment With All-trans Retinoic Acid and Intensive Chemotherapy
1998